Skip to main content

Table 1 Clinical patient characteristics

From: Treatment reality in elderly patients with advanced ovarian cancer: a prospective analysis of the OVCAD consortium

  Total (%) n = 275 Age < 70 years (%) n = 228 Age ≥ 70 years (%) n = 47 p value for group differences
Age (years)     <0.001a
Median 58 55 75  
Range 18-85 18-69 70-85  
FIGO stage     0.801c
IIB/C 15 (5.5) 13 (5.7) 2 (4.2)  
IIIA/B 16 (5.8) 13 (5.7) 3 (6.4)  
IIIC 196 (71.3) 165 (72.4) 31 (66.0)  
IV 48 (17.5) 37 (16.2) 11 (23.4)  
Nodal status     0.002b
pN0 65 (23.6) 58 (24.4) 7 (14.9)  
pN1 143 (52.0) 124 (54.4) 19 (40.4)  
Nx 67 (24.4) 46 (20.2) 21 (44.7)  
Grading     0.907c
G1 10 (3.6) 9 (4.0) 1 (2.1)  
G2 64 (23.4) 54 (23.8) 5 (21.3)  
G3 200 (73.0) 164 (72.2) 42 (76.6)  
Unknown 1 0 1  
Histological subtype     0.700c
Serous 237 (86.2) 194 (85.1) 43 (91.5)  
Mucinous 3 (1.1) 3 (1.3) 0 (0.0)  
Other* 13 (4.7) 31 (13.6) 4 (8.5)  
Presence of ascites     0.964b
None 66 (24.0) 54 (23.7) 12 (25.5)  
<500 ml 101 (36.7) 84 (36.8) 17 (36.2)  
>500 ml 108 (39.3) 90 (39.5) 18 (38.3)  
Peritoneal carcinomatosis     0.513b
Yes 186 (67.4) 156 (68.0) 30 (63.8)  
No 89 (32.4) 72 (32.0) 17 (36.2)  
ECOG     0.047c
0 166 (60.4) 139 (61.0) 27 (57.5)  
1 84 (30.6) 73 (32.0) 11 (23.4)  
≥2 12 (4.4) 7 (3.1) 5 (10.6)  
Unknown 13 (4.7) 9 (4.0) 4 (8.51)  
  1. Overview of the clinical characteristics of all included patients with advanced ovarian cancer (n = 275). A total of 47 elderly patients ≥70 years are opposed to 228 patients younger than 70 years.
  2. a Man-Whitney-U-test, b Chi2-test, c Fisher’s exact test.
  3. * other = clear cell, endometroid, mixed cell, undifferentiated histology.
  4. FIGO International Federation of Gynecology and Obstetrics.
  5. ECOG Eastern Cooperative Oncology Group performance status.